<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Analysis of the patterns of gene expression in follicular <z:hpo ids='HP_0002665'>lymphomas</z:hpo> from 24 patients suggested that two groups of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> might be distinguished </plain></SENT>
<SENT sid="1" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> patients, whose biopsies were obtained before any treatment, were treated with rituximab, a monoclonal antibody directed against the B cell antigen, CD20 </plain></SENT>
<SENT sid="2" pm="."><plain>Gene expression patterns in the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> that subsequently failed to respond to rituximab appeared more similar to those of <z:mpath ids='MPATH_458'>normal</z:mpath> lymphoid tissues than to gene expression patterns of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> from rituximab responders </plain></SENT>
<SENT sid="3" pm="."><plain>These findings suggest the possibility that the response of follicular <z:hpo ids='HP_0002665'>lymphoma</z:hpo> to rituximab treatment may be predicted from the gene expression pattern of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> </plain></SENT>
</text></document>